Personality Disorder, Depression, Neurodegeneration, Alzheimer's Disease, Epilepsy
Conditions
Brief summary
The main objective of the study is to evaluate the use of EEG in the management and follow-up of neuropsychiatric disorders. Secondary objectives are therefore better understanding of the pathological activations in neural network during neuropsychiatric disorders, their clinical evolution and response to therapies.
Detailed description
Patients are having EEG recordings as a routine part of their clinical evaluation and diagnosis. EEG recording is harmless, has no side effects, any radiation or any mechanical or electrical influence. It is of short duration and may be done in the EEG institute or the patient's room.
Interventions
EEG recording
Sponsors
Study design
Eligibility
Inclusion criteria
* diagnosis of the investigated neuropsychiatric disease
Exclusion criteria
* Other co-existing neuropsychiatric conditions * Refusal to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| percentage of fitting (0-100%) of EEG pattern to a previously identified electrophysiological key | 1 year | The study will decode an EEG-based key (or electrophysiological pattern) for specific effect (such as the use of anti-epileptic agent or a certain condition) by comparing EEG before and after the use of this agent. For each patient the statistical fitting of the recorded EEG to the key will be evaluated by percentage (0-100%), describing fitting of the individual patient's EEG to the identified key. |
Countries
Israel